Skip to main content Skip to navigation
Transcription Factor Phospho Buffer Set

Transcription Factor Phospho Buffer Set

(RUO)
Transcription Factor Phospho Buffer Set

Multicolor flow cytometric analysis of surface and intracellular markers coexpressed by previously-frozen and thawed human CD4+ T cells.

    Top Panel - IL-2-induced pSTAT5 (pY694) signaling responses by human CD4 T cell subsets defined by FoxP3. Frozen human peripheral blood mononuclear cells were thawed and cultured (37°C, 15 min) with 0.2, 0.4, 1 and 10 U/mL (or 12, 24, 61, 611 pg/mL, respectively) of recombinant human IL-2 protein. The cells were then fixed, permeabilized, and stained with fluorescent antibodies specific for CD3, CD4, FoxP3, and phosphorylated Stat5 (pY694) using the BD Pharmingen TFP Buffer Set and protocol. Two-color flow cytometric contour plots showing the correlated expression of FoxP3 versus phosphorylated Stat5 (pY694) were derived from CD3+ CD4+ gated events with the forward and side light-scatter characteristics of intact lymphocytes.

    Bottom Panel - CD4 T cell subsets defined by surface and intracellular markers. Frozen human peripheral blood mononuclear cells were thawed and then fixed and permeabilized using the BD Pharmingen TFP Buffer Set and protocol. Cells were labeled with surface (Anti-human CD4, CD45RA, and CD25) and intracellular (Anti-FoxP3) antibodies after treatment with Perm III. Two-color flow cytometric contour plots showing the correlated expression of FoxP3 versus CD25 (Left Plot) or CD45RA (Right Plot) were derived from CD3+ CD4+ gated events with the forward and side light-scatter characteristics of intact lymphocytes.

    Data courtesy of Yang, Hsiu-Mien, King College London, UK.

Transcription Factor Phospho Buffer Set

Multicolor flow cytometric analysis Stat5 (pY694) expression by human T cell subsets in response to different IL-2 doses. Human peripheral blood mononuclear cells were not cultured (No Stim) or were cultured (IL-2; 37ºC for 15 min) with 1, 10, or 100 ng/mL doses of Recombinant Human IL-2 protein (Cat. No. 554603) as indicated. The cells were then fixed, permeabilized, and stained with fluorescent antibodies specific for surface (CD3, CD4, CD8, CD25, CD45RA) and intracellular (FoxP3, T-bet, pStat5 pY694) markers using the BD Pharminhen TFP Buffer Set and protocol. The fluorescence histograms showing Stat5 (pY694) expression were derived from CD3-negative or CD3-positive gated events with CD45RA+ T-bet-, CD45RA- Tbet+, or CD45RA- T-bet- phenotypes and with the forward and side light-scatter characteristics of intact lymphocytes as indicated.

Transcription Factor Phospho Buffer Set

Multicolor flow cytometric analysis of cytokine signaling responses in human T-cell and other leucocyte subsets defined by the correlated expression of FOXP3+ and T-bet+ or other markers. Human peripheral blood mononuclear cells were treated with 100 ng/mL of recombinant human IFN-α; 100 ng/mL IL-6; or 0.1, 1, 10, or 100 ng/mL of  IL-2 for 15 minutes at 37ºC and then fixed, permeabilized, and stained using the BD Pharmingen TFP Buffer Set as described in the protocol. Leucocyte subsets were identified by the correlated expression of FoxP3 and T-bet, and additional phenotypic markers specific for Th, Treg, NK, CD8 T cells, B cells, and monocytes using surface antibodies (Anti-Human CD45RA, CD3, CD4, CD20, and/or CD25). Patterns of Stat1, Stat 3, Stat 4, Stat 5 phosphorylation in response to cytokine stimulation are shown across leucocyte subsets in five donors. Heat maps display fold-change in phosphorylated STAT staining in response to stimulation.   * Not detected, <50 events acquired,

Multicolor flow cytometric analysis of surface and intracellular markers coexpressed by previously-frozen and thawed human CD4+ T cells.

    Top Panel - IL-2-induced pSTAT5 (pY694) signaling responses by human CD4 T cell subsets defined by FoxP3. Frozen human peripheral blood mononuclear cells were thawed and cultured (37°C, 15 min) with 0.2, 0.4, 1 and 10 U/mL (or 12, 24, 61, 611 pg/mL, respectively) of recombinant human IL-2 protein. The cells were then fixed, permeabilized, and stained with fluorescent antibodies specific for CD3, CD4, FoxP3, and phosphorylated Stat5 (pY694) using the BD Pharmingen TFP Buffer Set and protocol. Two-color flow cytometric contour plots showing the correlated expression of FoxP3 versus phosphorylated Stat5 (pY694) were derived from CD3+ CD4+ gated events with the forward and side light-scatter characteristics of intact lymphocytes.

    Bottom Panel - CD4 T cell subsets defined by surface and intracellular markers. Frozen human peripheral blood mononuclear cells were thawed and then fixed and permeabilized using the BD Pharmingen TFP Buffer Set and protocol. Cells were labeled with surface (Anti-human CD4, CD45RA, and CD25) and intracellular (Anti-FoxP3) antibodies after treatment with Perm III. Two-color flow cytometric contour plots showing the correlated expression of FoxP3 versus CD25 (Left Plot) or CD45RA (Right Plot) were derived from CD3+ CD4+ gated events with the forward and side light-scatter characteristics of intact lymphocytes.

    Data courtesy of Yang, Hsiu-Mien, King College London, UK.

Multicolor flow cytometric analysis Stat5 (pY694) expression by human T cell subsets in response to different IL-2 doses. Human peripheral blood mononuclear cells were not cultured (No Stim) or were cultured (IL-2; 37ºC for 15 min) with 1, 10, or 100 ng/mL doses of Recombinant Human IL-2 protein (Cat. No. 554603) as indicated. The cells were then fixed, permeabilized, and stained with fluorescent antibodies specific for surface (CD3, CD4, CD8, CD25, CD45RA) and intracellular (FoxP3, T-bet, pStat5 pY694) markers using the BD Pharminhen TFP Buffer Set and protocol. The fluorescence histograms showing Stat5 (pY694) expression were derived from CD3-negative or CD3-positive gated events with CD45RA+ T-bet-, CD45RA- Tbet+, or CD45RA- T-bet- phenotypes and with the forward and side light-scatter characteristics of intact lymphocytes as indicated.

Multicolor flow cytometric analysis of cytokine signaling responses in human T-cell and other leucocyte subsets defined by the correlated expression of FOXP3+ and T-bet+ or other markers. Human peripheral blood mononuclear cells were treated with 100 ng/mL of recombinant human IFN-α; 100 ng/mL IL-6; or 0.1, 1, 10, or 100 ng/mL of  IL-2 for 15 minutes at 37ºC and then fixed, permeabilized, and stained using the BD Pharmingen TFP Buffer Set as described in the protocol. Leucocyte subsets were identified by the correlated expression of FoxP3 and T-bet, and additional phenotypic markers specific for Th, Treg, NK, CD8 T cells, B cells, and monocytes using surface antibodies (Anti-Human CD45RA, CD3, CD4, CD20, and/or CD25). Patterns of Stat1, Stat 3, Stat 4, Stat 5 phosphorylation in response to cytokine stimulation are shown across leucocyte subsets in five donors. Heat maps display fold-change in phosphorylated STAT staining in response to stimulation.   * Not detected, <50 events acquired,

Product Details
Down Arrow Up Arrow


BD Pharmingen™
RUO
AB_2869473


Description

Protective immunity depends on coordinated responses between regulatory and conventional T cells and other leucocyte subsets. High resolution flow cytometric analyses of signaling responses made by leucocyte subsets, defined by their coexpressed levels of surface differentiation antigens and specific transcription factors, provides deep insights into the cellular and molecular mechanisms that underlie immune regulation in healthy and diseased states. Historically, disparate buffer compatibility characteristics have created challenges for the simultaneous analysis of these coexpressed biomarkers. The BD Pharmingen™ Transcription Factor Phospho (TFP) Buffer Set is designed to enable robust and simultaneous flow cytometric analysis of various cell surface antigens, transcription factors, and phosphorylated signal proteins in cells derived from both human and mouse tissues. This includes fresh, fixed, and frozen human peripheral blood mononuclear cells.

The BD Pharmingen™ TFP Buffer Set has been successfully applied to the multiparameter flow cytometric analysis of phosphorylated Stat signaling responses to cytokines made by human and mouse T regulatory cell and conventional T cell subsets, and other leucocyte types defined by certain cell surface markers, transcription factors (FoxP3 and T-bet), and physical characteristics. While not all antibody compatibilities are known, cell signaling responses to different stimuli should also be amenable to analysis using this buffer set and antibodies specific for other cell surface markers, transcription factors, and types of downstream phosphorylated signaling proteins. This buffer system is backwards compatible with many BD reagents, including antibodies conjugated with new fluorescent dyes (eg, BD Horizon™ BV421, BV510, PE-CF594, V450, and V500).

4X TFP Fix/Perm Buffer - Contains 15.6% formaldehyde, 5.5% methanol

Hazard statements

Combustible liquid.                                            Harmful if swallowed or in contact with skin.         Toxic if inhaled.

Causes skin irritation.                                         Causes serious eye damage.                                     May cause an allergic skin reaction.

Suspected of causing genetic defects.                May cause cancer. Route of exposure: Inhalative.

May cause damage to the central nervous system. Route of exposure: Oral. May cause respiratory irritation.

Precautionary statements

Wear protective gloves / eye protection.            Wear protective clothing.                                         Do not breathe mist/vapours/spray.

IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.  IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.  IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell

Perm Buffer III - Contains 88% methanol

Hazard statements

Highly flammable liquid and vapor.                      Toxic if swallowed, in contact with skin or if inhaled.

Causes damage to the central nervous system. Route of exposure: Oral.

Precautionary statements

Keep away from heat/sparks/open flames/hot surfaces. - No smoking.

Wear protective clothing / eye protection.              Wear protective gloves.                                    Do not breathe mist/vapours/spray.

IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower.  IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.

Recommended Assay Procedures

Protocol Outline

1. Cell Treatment: Prepare single cell suspension and pellet cells by centrifugation. Resuspend cells in 50-100 μL/test of 1× Dulbecco's PBS containing Ca++/Mg++, and then treat the cells (eg, with a response modifier).

2. Fix and permeabilize the cells with BD Pharmingen™ Transcription Factor Phospho (TFP) Buffer Set (Cat. No. 563239/565575).

3. Wash cells using 1× TFP Perm/Wash Buffer. Pellet cells by centrifugation and aspirate supernatants. Do not leave residual buffer supernatant

4. Incubate cells with BD Phosflow™ Perm Buffer III, pellet cells, and remove Perm Buffer III supernatant.

5. Wash cells with 1× TFP Perm/Wash Buffer and stain cells with fluorescent antibodies. Wash the cells with 1× TFP Perm/Wash Buffer.

6. Resuspend cells in BD Pharmingen™ Stain Buffer (BSA) (Cat. No. 554657) and analyze by flow cytometry.

General Comments                                                                                 

        The entire protocol is performed at 2-8ºC with two exceptions:

o        During the treatment of fresh cells in 1× DPBS with response modifier

o        When using Perm Buffer III which has been stored at -20ºC.

        Cool the centrifuge and prepare fluorescent antibody cocktails and other solutions prior to starting the protocol.

        Prepare the 1× TFP Perm/Wash Buffer from the 5× stock TFP Perm/Wash Buffer solution by diluting with filtered, deionized water.

        Also, prepare the 1× TFP Fix/Perm Buffer 10-15 minutes prior to use. Mix 4× TFP Fix/Perm Buffer stock with 0.75× TFP Diluent to make 1× TFP Perm/Wash Buffer (eg, use 10 ml of 4× TFP Fix/Perm Buffer stock and mix with 30 ml of 0.75× TFP Diluent).

        The time interval for staining cells with antibodies can likely be limited to 30 min. However, the original staining protocol was developed using at least 40 minute-incubation times.

        Keep centrifuge at 2-8ºC, and keep centrifuge speeds constant (380 g prior to cellular fixation, 500 g after fixation).

        There is no permeabilization incubation time introduced using the Perm/Wash Buffer. It is not necessary.

        This protocol is not optimized for use with whole blood.

Materials and Equipment

        1× Dulbecco's PBS (DPBS) containing Ca++/Mg++

        1× Dulbecco's PBS (DPBS) containing without Ca++/Mg++

        BD Pharmingen™ Transcription Factor Phospho Buffer Set (Cat. No. 563239/565575)

        BD Pharmingen™ Stain Buffer (BSA) (Cat. No. 554657)

        50 or 15 mL sterile polypropylene conical centrifuge tubes

        37ºC incubator or water bath

        Temperature controlled centrifuge capable of 200-600 g and accommodating flow cytometry tubes, 96 deep-well plates, and 15 and 50 mL conical tubes

        Samples: Peripheral blood mononuclear cells (PBMC) 1-2 million cells per test for bulk processing and flow cytometry tube. PBMC 0.75-to-1.0 million cells per test for HTS in deep-well plates and 96-well round bottom plates for HTS on the flow cytometer

        Heat-inactivated FBS with 7.5% DMSO freezing solution

        Flow cytometry tubes or 2.2 mL Storage Plate, MARK II (96 Deep Well; Abgene Cat. No. AB0932) and 96-well tissue culture plates

        Fluorescent antibodies specific for intracellular and cell surface antigens

        Multichannel pipettes that can deliver 20 μL, 200 μL or 1,000 μL volumes

Staining Cells in Tubes

1. Treat cell preparations (human or mouse ) with a response modifier, such as, a cytokine at suboptimal or saturating (eg, 50-100 units per mL) doses of interest, using a 1 mL suspension of 10-20 million cells (10 tests) in 1× DPBS with Ca++/Mg++. Note: Keep this volume of DPBS low, it is important to the intended effect of the 1× TFP Fix/Perm Buffer. Use a 50 mL polypropylene conical centrifuge tube for bulk cell treatment.

2. Incubate 15 min at 37 ºC, exactly, or use another specific treatment condition as desired.

3. Stop cell treatment by adding 1× TFP Fix/Perm Buffer to the cells. Note: Slowly add 10 mL of 1× TFP Fix/Perm Buffer (at 2-8ºC). Cap and invert tubes several times.

4. Incubate for 50 min at 2-8ºC to fix and permeabilize the cells.

5. Add 5 ml of 1× TFP Perm/Wash Buffer.

6. Centrifuge cells at 500 g (15 min at 2-8 ºC).

7. Aspirate supernatants away from pelleted cell samples, wash cells once with 10 mL 1× TFP Perm/Wash Buffer.

8. Centrifuge cells at 500 g (10 min); aspirate all residual supernatant volume away from pelleted cells.

Long Term Storage Option: After step 8, can resuspend cells in 200-500 μL FBS with 7.5% DMSO and freeze at -80ºC in cryopreservation tubes. Thaw by removing cells from freezer, adding equal volumes of cold TFP Perm/Wash Buffer, and thaw in cold water bath. Wash once with TFP Perm/Wash Buffer, and then proceed with the protocol from step 9.

  9. Add 1.0 mL Perm Buffer III (or other desired volume if doing in bulk) per 1-2 million cells

Notes: i) Perm Buffer III is taken from a -20ºC freezer. ii) Cell pellets become translucent during this step.

10. Incubate for 20 min on ice to allow exposure of the phosphorylated protein epitopes.

Short Term Storage Option #2: Store overnight at -20ºC. Cover tubes with Parafilm® and protect from moisture. Continue with protocol next day. If choosing to store samples in this manner, remove to 2-8 ºC and allow to warm for 5-10 minutes and proceed to step 11.

11. Centrifuge at 500 g (8 min, at 2-8ºC) and carefully aspirate Perm Buffer III being sure to remove all residual volume.

12. Wash once with 1× TFP Perm/Wash Buffer. Use 10 mL when using 50 mL conical tubes in bulk or 2 mL if using flow cytometry tubes; remove all residual buffer from the cell pellet after centrifugtion. Add 80-90 μL 1× TFP Perm/Wash Buffer per test and resuspend the cell pellets in preparation for staining. Optional: Repeat washing step to be sure to remove all Perm Buffer III. Failing to wash the methanol out well enough prior to staining can lead to destruction of protein fluorochromes and tandem dyes (eg, PerCP, PE, PE-Cy™7).

13. Staining with fluorescent antibodies: At this time it may be necessary or desirable to aliquot the cell samples into flow cytometry tubes for staining with different panels of fluorescent antibodies.

a. Intracellular Staining: Add antibodies specific for intracellular target antigens such as FoxP3, T-bet, phosphorylated Stat proteins, or other intracellular molecules as desired.

Note: It is known that when staining cells in TFP Perm/Wash Buffer, lower concentrations of antibodies are needed for intracellular staining, eg, 0.5× or 0.25× test size (usually 2.5 µL of a 5 µL test size). However, fluorescent antibodies specific for phosphorylated Stat proteins should be used at the stated test size on the vial.

Note: When staining Human FoxP3, antibody clone 236A is recommended for best results.  

b. Staining Surface Molecules: Prepare a cocktail of fluorescent antibodies specific for staining cell surface antigens in 1× TFP Perm/Wash Buffer or Stain Buffer (BSA). For example, dilute fluorescent surface antibodies at a 10 µL:1000 µL dilution to make a cocktail of 50 tests at 20 µL per test.

14. Incubate for 40-50 min at 2-8ºC

15. Wash cells once with 2 mL 1× TFP Perm/Wash Buffer, centrifuge cell suspensions at 500 g for 5 min at 2-8ºC, and aspirate supernatants away from the pelleted cells.

16. Resuspend cells in 350 μL Stain Buffer (Cat. No. 554657). Note: do not resuspend cells in 1× TFP Perm/Wash Buffer!

17. Acquire a sufficient number of events by flow cytometry to obtain statistically significant results, eg, ≥ 15,000 CD4+ or ≥ 150 FoxP3+ events, as the case may be. Due to the fixation and permeabilization procedure, forward and side light-scatter signals can be slightly different than those of live cells.

Staining Cells in 96-Well Plates

Use 2.2 mL Storage Plate, MARK II (96 Deep Well; Abgene Cat. No. AB0932) and 96-well tissue culture plates

1. Treat cell preparations (human or mouse) with response modifiers (as above) in 96 deep-well plate using cells at 0.5-1.0 million cells/well in 1× DPBS with Ca++/Mg++. For example: start with 50 μL of cells at 10-20 million cells/mL (0.5-1 million cells/well) and add 20 μL of response modifier (diluted in DPBS + 1 mg/mL BSA), for a final cell + response modifier volume of 70 μL.

2. Incubate 15 min at 37 ºC, exactly, or use another specific treatment condition as desired.

3. Stop cell treatment by adding 1× TFP Fix/Perm Buffer to the cells. Use a 1.2 mL multichannel pipette to add 1.0 mL of cold 1× TFP Fix/Perm Buffer.  Mix thoroughly by pipetting up and down several times.

4. Incubate for 50 min at 2-8ºC to fix and permeabilize the cells.

5. Add 350 μL of 1× TFP Perm/Wash Buffer to each well.

6. Centrifuge cells at 500 g for 8 min at 2-8ºC.

7. Aspirate supernatants from samples and wash cells once with 700 μL of 1× TFP Perm/Wash Buffer.

8. Centrifuge cells at 500 g for 8 min and aspirate all residual supernatant volume away from pelleted cells.

Long Term Storage Option: After step 8, resuspend cells in each well with 200-500 μL FBS with 7.5% DMSO and freeze at -80ºC. Thaw by removing cells from freezer, adding 1 mL cold TFP Perm/Wash Buffer, and thawing plate in a cold water bath. Wash cells with TFP Perm/Wash Buffer one additional time, and then proceed with the protocol from step 9.

9. Before adding any buffer to the plate, vortex to resuspend the cells. Add 500 μL of Perm Buffer III per well, and pipette up and down to mix.

Notes: i) Perm Buffer III is taken from -20 ºC freezer prior to use. ii) Cell pellets turn translucent during this step.

10. Incubate for 20 min on ice to allow exposure of the phosphorylated epitopes.

Short Term Storage Option: Store overnight at -20ºC. Cover plate with lid, secure it with Parafilm® and protect from moisture. Continue with protocol next day. If choosing to store samples in this manner, remove plate to 2-8 ºC and allow to warm for 5-10 minutes and proceed to step 11.

11. Centrifuge cells at 500 g for 8 min at 2-8 ºC, carefully aspirate Perm Buffer III supernatant away from pelleted cells.

12. Wash once with 1×  TFP Perm/Wash Buffer, 1 mL each per well and centrifuge; remove all residual buffer.

Optional: Repeat washing step to be sure to remove all Perm Buffer III. Failing to wash the methanol out well enough prior to staining can lead to destruction of the protein fluorochrome and tandem dyes (eg, PE, PerCP, PE-Cy™7, etc.). Resuspend cells in 100 μL 1× TFP Perm/Wash Buffer.

13. Staining with fluorescent antibodies: 

a. Intracellular Staining: Add antibodies specific for intracellular target antigens such as FoxP3, T-bet, phosphorylated Stat proteins or other intracellular molecules as desired.

Note: It is known that when staining cells in TFP Perm/Wash Buffer, lower concentrations of antibodies are needed for intracellular staining, eg, 0.5× or 0.25× test size (usually 2.5 µL of a 5 µL test size). However, fluorescent antibodies specific for phosphorylated Stat proteins should be used at the stated test size on the vial.

Note: When staining Human FoxP3, antibody clone 236A is recommended for better results  

b. Staining Surface Molecules: Prepare a cocktail of fluorescent antibodies specific for staining cell surface antigens in 1× TFP Perm Wash Buffer or Stain Buffer (BSA). For example, dilute fluorescent surface antibodies at a 10 µL:1000 µL dilution to make a cocktail of 50 tests at 20 µL per test. Add this test volume to the tube after adding the intracellular antibodies.

14. Incubate for 40-50 min at 2-8ºC

15. Wash cells once or twice with 200 μL TFP Perm/Wash Buffer, centrifuge at 500 g for 5 min at 2-8ºC; carefully aspirate sample supernatants. Transfer cells to standard, round-bottom 96-well plates for acquisition.

16. Resuspend pelleted cells in 200 μL Stain Buffer (BSA) (Cat. No. 554657). Note: do not resuspend in 1× TFP Perm/Wash Buffer!

17. Acquire a sufficient number of events in order to obtain statistically significant results, eg, ≥ 15,000 CD4+ or ≥ 150 FoxP3+ events, as the case may be.

            Antibodies Tested as Compatible for Staining using the BD Pharmingen™ Transcription Factor Phospho Buffer Set

Description        Clone        Reactivity        Formats Tested        Cat. No.

CD3        SK7        Hu        PE        340662

CD3        UCHT1        Hu        PerCP-Cy5.5,         560835, 562427, 560365

                        BD Horizon™ BV421 and V450        

CD4        SK3        Hu        BV510, PerCP-Cy5.5        562970, 562971, 560650

CD20         HI (FB1)        Hu        Alexa Fluor® 700        561171

CD21        B-ly4        Hu        APC        559867

CD25        2A3, MA251        Hu        PE, BD Horizon™ BV421        564033, 557138, 341010,

                                564033, 562442

CD45RA        HI100        Hu        PE-Cy™7        560675

CD3        17A2        Ms        APC-Cy™7, BV421        560590, 564008

CD4        RM4-5        Ms        PerCP-Cy5.5        553050

CD25        3C7        Ms        BV421        564370

Stat1 (pY701)        4a        Hu, Ms        Alexa Fluor® 647        612597

Stat3 (pY705)        4/P-STAT3        Hu, Ms        Alexa Fluor® 647        557815

Stat4 (pY693)        38/p-Stat4        Hu, Ms        Alexa Fluor® 647        558137

Stat5 (pY694)        47/Stat5(pY694)        Hu, Ms        Alexa Fluor® 647        562076, 612599

Stat6 (pY641)        23/Stat6, 18/P-Stat6         Hu, Ms        Alexa Fluor® 647        560000, 612601

CD247, CD3 Zeta (pY142)        K25-407.69        Hu        Alexa Fluor® 647        558489

ZAP-70 (PY319)/Syk (PY352)        17A/P-ZAP70        Hu        Alexa Fluor® 647        557817

SLP-76 (pY128)        H3        Hu        Alexa Fluor® 647        560057

AKT (pS473)        M8961        Hu        Alexa Fluor® 647        560343

LAT (pY171)        158-1169        Hu        Alexa Fluor® 647        559518

ERK 1/2 (pT202/pY204)        20A        Hu        Alexa Fluor® 647        561992

Ki-67        B56        Hu        Alexa Fluor® 647        561126

FOXP3        259D/C7        Hu        Alexa Fluor® 488, PE        560047, 560046

FOXP3        236A/E7        Hu        Alexa Fluor® 488, PE        561181, 560852

FOXP3        MF23        Ms        Alexa Fluor® 488, PE        560407, 561181

T-bet        O4-46        Hu, Ms        PE, PE-CF594        561268, 562467

GATA3        L50-823        Hu        PE        560074

EZH2 PE        11/EZH2        Hu        PE        562478

BMI-1        P51-311        Hu        PE        562528

Pax-5        1H9        Hu        PE        562688

Fixable Viability Stain 450        N/A        Hu        BD Horizon™ V450        562247

All formats of the antibodies listed were tested and found to work in staining cells using the BD Pharmingen™ Transcription Factor Phospho Buffer Set. This buffer is likely to work with other formats of the same clones as well as other antibodies. However, they have not been tested.

Product Notices

  1. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
  2. Alexa Fluor® is a registered trademark of Molecular Probes, Inc., Eugene, OR.
  3. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
  4. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
  5. Cy is a trademark of GE Healthcare.
563239 Rev. 4
Components
Down Arrow Up Arrow
Description Quantity/Size Part Number EntrezGene ID
0.75X TFP Diluent Buffer 75 mL (1 ea) 51-9011462 N/A
4X TFP Fix/Perm Buffer 25 mL (1 ea) 51-9011319 N/A
Perm Buffer III 125 mL (1 ea) 51-9011461 N/A
5X TFP Perm/Wash Buffer 150 mL (1 ea) 51-9011463 N/A
563239 Rev. 4
Citations & References
Down Arrow Up Arrow

Development References (12)

  1. Garg G, Tyler JR, Yang JH, et al. Type 1 diabetes associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function. J Immunol. 2012; 188(9):4644-4653. (Methodology). View Reference
  2. Hingorani R, Vidal J, Le H., Waterman, P Rohrer J, and Boyce CS. Optimized buffer system for detection of transcription factors and surface proteins in T cells validated in high throughput screening of activated T-regulatory cells. J Immunol. 188(124.10)Available: http://www.jimmunol.org/cgi/content/meeting_abstract/188/1_MeetingAbstracts/124.10 3/5/2015.
  3. Krutzik PO, Nolan GP. Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Methods. 2006; 3(5):361-368. (Methodology). View Reference
  4. Montag DT, Lotze MT. Rapid flow cytometric measurement of cytokine-induced phosphorylation pathways [CIPP] in human peripheral blood leukocytes. Clin Immunol. 2006; 121(2):215-226. (Methodology). View Reference
  5. Montag DT, Lotze MT. Successful simultaneous measurement of cell membrane and cytokine induced phosphorylation pathways [CIPP] in human peripheral blood mononuclear cells. J Immunol Methods. 2006; 313(1-2):48-60. (Methodology). View Reference
  6. Passerini L, Allan SE, Battaglia M, et al. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells. Int Immunol. 2008; 20(3):421-431. (Methodology). View Reference
  7. Perez OD, Mitchell D, Campos R, Gao GJ, Li L, Nolan GP. Multiparameter analysis of intracellular phosphoepitopes in immunophenotyped cell populations by flow cytometry. Curr Protoc Cytom. 2005; 6.20.1-6.20.22. (Methodology). View Reference
  8. Perez OD, Mitchell D, Jager GC, et al. Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1. Nat Immunol. 2003; 4(11):1083-1092. (Methodology). View Reference
  9. Perez OD, Nolan GP. Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level. Immunol Rev. 2006; Apr(210):208-228. (Methodology). View Reference
  10. Suni MA, Maino VC. Flow cytometric analysis of cell signaling proteins. Methods Mol Biol. 2011; 717:155-169. (Methodology). View Reference
  11. Wu S, Jin L, Vence L, Radvanyi LG. Development and application of 'phosphoflow' as a tool for immunomonitoring. Expert Rev Vaccines. 2010; 9(6):631-643. (Methodology). View Reference
  12. Wu XW, Boyce CS, O'Donnell E, Ernst D, Wang X, and Gao GJ. Cytokine signaling responses differ between FoxP3+ and T-bet+ T cell subsets in both mouse and human (P1331). J Immunol. 190(208.9)Available: http://www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/208.9 3/5/2105.
View All (12) View Less
563239 Rev. 4

Please refer to Support Documents for Quality Certificates

Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described

Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.